A new study shows that the SARS-CoV-2 Omicron variant is less effective than Delta at blocking a cellular defense mechanism against viruses, the so-called ‘interferon response’. Moreover, cell culture findings indicate that eight important COVID-19 drugs and drug candidates remain effective against Omicron.
